Search Results 71-80 of 258 for ⌛메이저놀이터 [원탑보증.com/가입코드 111] 올인구조대 ⌛
The primary objective of this study is to observe the long-term safety of filgotinib in adults who have completed or met protocol specified efficacy ...
After completing standard-of-care (SOC) CDI antibiotics for their most recent CDI recurrence, patients who meet all eligibility requirements will be randomized ...
The purpose of this study is to determine the sensitivity of the Elephas Platform for predicting in-vivo clinical response based on surgical response or RECIST ...
Navitoclax and sorafenib tosylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Participation eligibility.
About this study. This phase II trial studies how well sapanisertib works in treating patients with acute lymphoblastic leukemia that has returned after a ...
About this study. This pilot, phase II trial studies how well everolimus and letrozole work in treating patients with hormone receptor positive ovarian, ...
This phase II trial studies how well midostaurin and decitabine work in treating older patients with newly diagnosed acute myeloid leukemia and fms-related ...
About this study. In this study researchers want to find out more about the side effects of a new drug for Philadelphia chromosome-positive (Ph+) acute ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift now to help create new and better solutions for the more than 1.3 million patients who turn to Mayo Clinic each year.